The concentration of inflammatory parameters (TNF-α and IL-10) in serum (a and b) and burned skin samples (c) of different experimental groups on day 2 and 10. حسب Omid Mehrpour (9385929)

The concentrations of malondialdehyde (a), super oxide dismutase (b), and NOx (nitrate +nitrite)(c) in the burned skin samples of different experimental groups on day 2 and 10. حسب Omid Mehrpour (9385929)

PP1/PP2A does not dephosphorylate pS295 <i>in vitro</i>. حسب Takahiko Chimura (729098)

"…The decrease of phosphorylated GSK3β (pGSK3β(S9)) was completely suppressed by the PP1/PP2A inhibitor calyculin A. …"

Renal (urea and creatinine) (a, b) and Liver function (ALT and AST) (c, d) test in serums of different experimental groups and body weight changes (e) on day 10. حسب Omid Mehrpour (9385929)

Impaired development of the brain and iBAT of rarely alive adult <i>aP2-Drp1</i>^f/f mice. حسب Yuta Ibayashi (20404811)

Dynamics of EGFP and mRFP fluorescence in infected cells under different heat shock conditions. حسب Enrique Paz-Cortés (20988196)

Funnel plots of studies included in the meta-analysis assessing حسب Solima Sabeel (9545738)

Overall analysis of randomized controlled trials. حسب Solima Sabeel (9545738)

"…Stratification by a longer treatment duration of more than four months revealed that atorvastatin achieved the most significant reduction in IL-6 and TNF-α. …"

Newcastle-Ottawa scale. حسب Solima Sabeel (9545738)

"…Stratification by a longer treatment duration of more than four months revealed that atorvastatin achieved the most significant reduction in IL-6 and TNF-α. …"

Meta-analysis showing the overall effect of different statin types versus placebo for حسب Solima Sabeel (9545738)

Stratified meta-analysis for treatment duration effects of statins versus placebo subdivided into 3-4 months and longer than 4 months of treatment for حسب Solima Sabeel (9545738)

Reason for exclusion of all 6514 screened articles. حسب Solima Sabeel (9545738)

Methodological items for non-randomized studies (MINORS). حسب Solima Sabeel (9545738)

Jadad Score of randomized controlled trials. حسب Solima Sabeel (9545738)

Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials. حسب Solima Sabeel (9545738)

Analysis of randomized controlled trials stratified based on treatment duration. حسب Solima Sabeel (9545738)

PRISMA flow diagram of the systematic literature search process. حسب Solima Sabeel (9545738)

Excluded skewed studies. حسب Solima Sabeel (9545738)

Summary of randomized controlled trials. حسب Solima Sabeel (9545738)

Summary of non-randomized studies. حسب Solima Sabeel (9545738)